相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。Predictive Values of Pathological and Clinical Risk Factors for Positivity of Sentinel Lymph Node Biopsy in Thin Melanoma: A Systematic Review and Meta-Analysis
Hanzi Huang et al.
FRONTIERS IN ONCOLOGY (2022)
HMB45 protein expression and the immunohistochemical maturation in common blue nevi: a reappraisal
Mahmoud Rezk Abdelwahed Hussein
ANAIS BRASILEIROS DE DERMATOLOGIA (2022)
Breslow thickness 2.0: Why gene expression profiling is a step toward better patient selection for sentinel lymph node biopsies
Mariana B. Sadurni et al.
MODERN PATHOLOGY (2022)
The detectability of intraepidermal melanocytes-A narrative review of immunohistochemical studies
Lukasz Kuzbicki et al.
JOURNAL OF CUTANEOUS PATHOLOGY (2022)
Survival in 31 670 patients with thin melanomas: a Swedish population-based study
K. Isaksson et al.
BRITISH JOURNAL OF DERMATOLOGY (2021)
Melanoma: Staging and Follow-Up
Chryssoula Papageorgiou et al.
DERMATOLOGY PRACTICAL & CONCEPTUAL (2021)
Epidemiology and Risk Factors of Melanoma: A Review
Claudio Conforti et al.
DERMATOLOGY PRACTICAL & CONCEPTUAL (2021)
PRAME Immunohistochemistry as an Ancillary Test for the Assessment of Melanocytic Lesions
Cecilia Lezcano et al.
Surgical Pathology Clinics (2021)
Lichenoid dermatoses with pseudomelanocytic nests vs inflamed melanoma in situ: A comparative study
Gauri Panse et al.
JOURNAL OF CUTANEOUS PATHOLOGY (2021)
Risk factors of recurrence and distant metastasis in primary cutaneous melanoma in Taiwan
Tung-Lin Lee et al.
SCIENTIFIC REPORTS (2021)
Rate of Immunohistochemistry Utilization in the Diagnosis of Cutaneous Melanocytic Lesions
Tony C. Chen et al.
AMERICAN JOURNAL OF DERMATOPATHOLOGY (2021)
Comparison of SOX-10, HMB-45, and Melan-A in Benign Melanocytic Lesions
Sabrina E. Dass et al.
CLINICAL COSMETIC AND INVESTIGATIONAL DERMATOLOGY (2021)
Aetiology and Pathogenesis of Cutaneous Melanoma: Current Concepts and Advances
Strahil Strashilov et al.
INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2021)
How Neural Crest Transcription Factors Contribute to Melanoma Heterogeneity, Cellular Plasticity, and Treatment Resistance
Anja Wessely et al.
INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2021)
Histological regression in melanoma: impact on sentinel lymph node status and survival
Karina Aivazian et al.
MODERN PATHOLOGY (2021)
Immunohistochemical Staining in the Assessment of Melanoma Tumor Thickness
Kambiz Kamyab-Hesary et al.
PATHOLOGY & ONCOLOGY RESEARCH (2020)
Immunohistochemistry utilization in the diagnosis of melanoma
Matthew S. Dinehart et al.
JOURNAL OF CUTANEOUS PATHOLOGY (2020)
Sentinel Lymph Node Biopsy for T1b Melanoma: Balancing Prognostic Value and Cost
Yinin Hu et al.
ANNALS OF SURGICAL ONCOLOGY (2020)
Melanoma Biomarkers and Their Potential Application for In Vivo Diagnostic Imaging Modalities
Monica Hessler et al.
INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2020)
Overcoming Immune Evasion in Melanoma
Kevinn Eddy et al.
INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2020)
Cutaneous Melanoma-A Review in Detection, Staging, and Management
Rebecca I. Hartman et al.
HEMATOLOGY-ONCOLOGY CLINICS OF NORTH AMERICA (2019)
Number of levels required to assess Breslow thickness in cutaneous invasive melanoma: An observational study
Jamie Bishop et al.
JOURNAL OF CUTANEOUS PATHOLOGY (2019)
Prognostic factors for metastasis in cutaneous melanoma
Ana Carolina Figueiredo Pereira Cherobin et al.
ANAIS BRASILEIROS DE DERMATOLOGIA (2018)
Long-Term Survival of Patients with Thin (T1) Cutaneous Melanomas: A Breslow Thickness Cut Point of 0.8 mm Separates Higher-Risk and Lower-Risk Tumors
Serigne N. Lo et al.
ANNALS OF SURGICAL ONCOLOGY (2018)
The eighth edition American Joint Committee on Cancer (AJCC) melanoma staging system: implications for melanoma treatment and care
Emily Z. Keung et al.
EXPERT REVIEW OF ANTICANCER THERAPY (2018)
A quantitative comparison between SOX10 and MART-1 immunostaining to detect melanocytic hyperplasia in chronically sun-damaged skin
Sonal Muzumdar et al.
JOURNAL OF CUTANEOUS PATHOLOGY (2018)
Metastases risk in thin cutaneous melanoma: prognostic value of clinical-pathologic characteristics and mutation profile
Antonio G. Richetta et al.
Oncotarget (2018)
Immunostain use in the diagnosis of melanomas referred to a tertiary medical center: a 15-year retrospective review (2001-2015)
Randie H. Kim et al.
JOURNAL OF CUTANEOUS PATHOLOGY (2017)
Melanocytic nevi and melanoma: unraveling a complex relationship
W. E. Damsky et al.
ONCOGENE (2017)
Melanoma staging: Evidence-based changes in the American Joint Committee on Cancer eighth edition cancer staging manual
Jeffrey E. Gershenwald et al.
CA-A CANCER JOURNAL FOR CLINICIANS (2017)
Diagnostic utility of epithelial and melanocitic markers with double sequential immunohistochemical staining in differentiating melanoma in situ from invasive melanoma
Rafael Parra-Medina et al.
ANNALS OF DIAGNOSTIC PATHOLOGY (2017)
Sentinel Lymph Node Biopsy in Thin Cutaneous Melanoma: A Systematic Review and Meta-Analysis
Erin Cordeiro et al.
ANNALS OF SURGICAL ONCOLOGY (2016)
Long-term Survival of Patients With Invasive Ultra-thin Cutaneous Melanoma A Single-center Retrospective Analysis
Antonella Vecchiato et al.
MEDICINE (2016)
Can SOX-10 or KBA.62 Replace S100 Protein in Immunohistochemical Evaluation of Sentinel Lymph Nodes for Metastatic Melanoma?
Elena Vrotsos et al.
APPLIED IMMUNOHISTOCHEMISTRY & MOLECULAR MORPHOLOGY (2016)
Detection of Occult Invasion in Melanoma In Situ
Michael J. Bax et al.
JAMA DERMATOLOGY (2016)
Expression of microphthalmia transcription factor, S100 protein, and HMB-45 in malignant melanoma and pigmented nevi
Jianxin Xia et al.
BIOMEDICAL REPORTS (2016)
Breslow Thickness Determined With the Use of Immunohistochemical Techniques Could Provide Misleading Information When Used With Prognostic Models Based on Data Obtained by Conventional Means
Thomas N. Helm et al.
AMERICAN JOURNAL OF DERMATOPATHOLOGY (2014)
Value of melanocytic-associated immunohistochemical markers in the diagnosis of malignant melanoma: a review and update
Nelson G. Ordonez
HUMAN PATHOLOGY (2014)
Prediction of Survival in Patients With Thin Melanoma: Results From a Multi-Institution Study
Andrea Maurichi et al.
JOURNAL OF CLINICAL ONCOLOGY (2014)
Interobserver Variability of Histopathological Prognostic Parameters in Cutaneous Malignant Melanoma: Impact on Patient Management
Hanna Eriksson et al.
ACTA DERMATO-VENEREOLOGICA (2013)
Differences in Tumor Thickness Between Hematoxylin and Eosin and Melan-A Immunohistochemically Stained Primary Cutaneous Melanomas
Marina Drabeni et al.
AMERICAN JOURNAL OF DERMATOPATHOLOGY (2013)
Clinical and Pathologic Factors Associated with Distant Metastasis and Survival in Patients with Thin Primary Cutaneous Melanoma
Rajmohan Murali et al.
ANNALS OF SURGICAL ONCOLOGY (2012)
S100-Negative Junctional Melanocytic Proliferations
Morgan L. Wilson et al.
AMERICAN JOURNAL OF DERMATOPATHOLOGY (2011)
Differential expression of S100 protein subtypes in malignant melanoma, and benign and malignant peripheral nerve sheath tumors
Daisuke Nonaka et al.
JOURNAL OF CUTANEOUS PATHOLOGY (2008)
Reliability of diagnosis of melanoma in situ
M Megahed et al.
LANCET (2002)
Inter-observer variation in the histopathological diagnosis of clinically suspicious pigmented skin lesions
L Brochez et al.
JOURNAL OF PATHOLOGY (2002)
Analysis of SOX10 function in neural crest-derived melanocyte development: SOX10-dependent transcriptional control of dopachrome tautomerase
SB Potterf et al.
DEVELOPMENTAL BIOLOGY (2001)
分享论文
